Journal
CANCER MANAGEMENT AND RESEARCH
Volume 13, Issue -, Pages 297-306Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S280174
Keywords
gastrointestinal stromal tumor; NF1; KIT; deep sequencing
Categories
Funding
- National Natural Science Foundation of China [81200366, 81572281, 81702278, 81974367]
- Province Natural Science Foundation of Hunan [14JJ6004]
- Key Subject Education Department of Hunan [[2012]594]
- Scientific Research Project of Hunan Provincial Department of Education [18K001]
Ask authors/readers for more resources
In NF1-deficient GISTs, about 48% of cases have concurrent mKIT mutations, especially in Chinese populations. These gain-of-function mKIT mutations are mostly located in exon 11 of the KIT gene. The presence of mKIT in NF1-associated GISTs is not associated with patient age, gender, or location.
Purpose: NF1-deficient GISTs account for about 1% of gastrointestinal stromal tumors (GISTs) and are usually considered as a subtype of KIT/PDGFRA wild-type GISTs that have no detectable KIT and PDGFRA mutations. Some KIT/PDGFRA wild-type GISTs actually have cryptic KIT mutations (mKIT). So we investigate whether concurrent mKIT existed in NF1-associated GISTs. Patients and Methods: Three independent cohorts were retrospectively analyzed. KIT/ PDGFRA wild-type GISTs in Xiangya Hospital between May 2017 and Oct 2019 were investigated by next-generation sequencing (NGS) approach targeted 1021 cancer-related genes regions. GISTs cases in Gene+ dataset from May 2017 to May 2020 were collected from the platform of this company. The genotypes of GISTs in MSKCC cohort were downloaded from cBioPortal. Results: A total of 290 cases including 23 KIT/PDGFRA wild-type GISTs in Xiangya Hospital, 136 GISTs in Gene+ database, and 131 GISTs in MSKCC were enrolled. Twenty-six cases have NF1 mutations (mNF1), and 48% (12/26) of NF1-mutated GISTs have concurrent mKIT. Compared with MSKCC (2/10, 20%), a higher ratio of mKIT in NF1-associated GISTs was detected in Xiangya Hospital (3/5, 60%) and Gene+ (7/11, 64%) (p<0.05). No mutation hotspot existed in mNF1. Most of mKIT centered within exon 11 (7/12, 58%) and others including exon 17 (3/12, 25%), exon 9(1/12, 8%), exon 13 (1/12, 8%) and exon 21 (1/12, 8%). No differences in age, gender, and location were detected between NF/-related GISTs with mKIT and those without mKIT. Three GIST cases of type I neurofibromatosis, skin neurofibromas and micro-GISTs (<= 1 cm) were devoid of mKIT, but all the mini-GISTs (1 similar to 2 cm) and clinic GIST lesions (>2 cm) in two cases harbored mKIT. Conclusion: mKIT was not unusual in NF1-associated GISTs, especially in Chinese populations. The gain-of-function mKIT possibly facilitated the progression of NF1-deficient lesions to clinic GISTs, however, the underlying mechanism warrants further studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available